Global Opioids Drug Market Research Report 2021
Global Opioids Drug Market Research Report 2021
The Opioids Drug study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Opioids Drug Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Opioids Drug Market Overview:
Global Opioids Drug Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Opioids Drug involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Opioids Drug Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Opioids Drug market in 2020.
Global Opioids Drug Market Segmentation
By Type, Opioids Drug market has been segmented into:
Oxycodone
Hydromorphone
Codeine
Fentanyl
Others
By Application, Opioids Drug market has been segmented into:
Pain Relief
Anesthesia
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Opioids Drug market are:
Purdue Pharma
J&J
Teva
Mylan
Depomed
INSYS
Endo
Pfizer
Hikma
Mallinckrodt
Pernix
Egalet
Vistapharm
1. Market Overview of Opioids Drug
1.1 Opioids Drug Market Overview
1.1.1 Opioids Drug Product Scope
1.1.2 Market Status and Outlook
1.2 Opioids Drug Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Opioids Drug Historic Market Size by Regions (2015-2020)
1.4 Opioids Drug Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Opioids Drug Sales Market by Type (2015-2026)
2.1 Global Opioids Drug Historic Market Size by Type (2015-2020)
2.2 Global Opioids Drug Forecasted Market Size by Type (2021-2026)
2.3 Oxycodone
2.4 Hydromorphone
2.5 Codeine
2.6 Fentanyl
2.7 Others
3. Covid-19 Impact Opioids Drug Sales Market by Application (2015-2026)
3.1 Global Opioids Drug Historic Market Size by Application (2015-2020)
3.2 Global Opioids Drug Forecasted Market Size by Application (2021-2026)
3.3 Pain Relief
3.4 Anesthesia
3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Opioids Drug Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Opioids Drug Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Opioids Drug Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Opioids Drug Business
5.1 Purdue Pharma
5.1.1 Purdue Pharma Company Profile
5.1.2 Purdue Pharma Opioids Drug Product Specification
5.1.3 Purdue Pharma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 J&J
5.2.1 J&J Company Profile
5.2.2 J&J Opioids Drug Product Specification
5.2.3 J&J Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Teva
5.3.1 Teva Company Profile
5.3.2 Teva Opioids Drug Product Specification
5.3.3 Teva Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Mylan
5.4.1 Mylan Company Profile
5.4.2 Mylan Opioids Drug Product Specification
5.4.3 Mylan Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Depomed
5.5.1 Depomed Company Profile
5.5.2 Depomed Opioids Drug Product Specification
5.5.3 Depomed Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 INSYS
5.6.1 INSYS Company Profile
5.6.2 INSYS Opioids Drug Product Specification
5.6.3 INSYS Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Endo
5.7.1 Endo Company Profile
5.7.2 Endo Opioids Drug Product Specification
5.7.3 Endo Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Pfizer
5.8.1 Pfizer Company Profile
5.8.2 Pfizer Opioids Drug Product Specification
5.8.3 Pfizer Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Hikma
5.9.1 Hikma Company Profile
5.9.2 Hikma Opioids Drug Product Specification
5.9.3 Hikma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Mallinckrodt
5.10.1 Mallinckrodt Company Profile
5.10.2 Mallinckrodt Opioids Drug Product Specification
5.10.3 Mallinckrodt Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 Pernix
5.11.1 Pernix Company Profile
5.11.2 Pernix Opioids Drug Product Specification
5.11.3 Pernix Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Egalet
5.12.1 Egalet Company Profile
5.12.2 Egalet Opioids Drug Product Specification
5.12.3 Egalet Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 Vistapharm
5.13.1 Vistapharm Company Profile
5.13.2 Vistapharm Opioids Drug Product Specification
5.13.3 Vistapharm Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Opioids Drug Market Size (2015-2026)
6.2 North America Opioids Drug Key Players in North America (2015-2020)
6.3 North America Opioids Drug Market Size by Type (2015-2020)
6.4 North America Opioids Drug Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Opioids Drug Market Size (2015-2026)
7.2 East Asia Opioids Drug Key Players in North America (2015-2020)
7.3 East Asia Opioids Drug Market Size by Type (2015-2020)
7.4 East Asia Opioids Drug Market Size by Application (2015-2020)
8. Europe
8.1 Europe Opioids Drug Market Size (2015-2026)
8.2 Europe Opioids Drug Key Players in North America (2015-2020)
8.3 Europe Opioids Drug Market Size by Type (2015-2020)
8.4 Europe Opioids Drug Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Opioids Drug Market Size (2015-2026)
9.2 South Asia Opioids Drug Key Players in North America (2015-2020)
9.3 South Asia Opioids Drug Market Size by Type (2015-2020)
9.4 South Asia Opioids Drug Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Opioids Drug Market Size (2015-2026)
10.2 Southeast Asia Opioids Drug Key Players in North America (2015-2020)
10.3 Southeast Asia Opioids Drug Market Size by Type (2015-2020)
10.4 Southeast Asia Opioids Drug Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Opioids Drug Market Size (2015-2026)
11.2 Middle East Opioids Drug Key Players in North America (2015-2020)
11.3 Middle East Opioids Drug Market Size by Type (2015-2020)
11.4 Middle East Opioids Drug Market Size by Application (2015-2020)
12. Africa
12.1 Africa Opioids Drug Market Size (2015-2026)
12.2 Africa Opioids Drug Key Players in North America (2015-2020)
12.3 Africa Opioids Drug Market Size by Type (2015-2020)
12.4 Africa Opioids Drug Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Opioids Drug Market Size (2015-2026)
13.2 Oceania Opioids Drug Key Players in North America (2015-2020)
13.3 Oceania Opioids Drug Market Size by Type (2015-2020)
13.4 Oceania Opioids Drug Market Size by Application (2015-2020)
14. South America
14.1 South America Opioids Drug Market Size (2015-2026)
14.2 South America Opioids Drug Key Players in North America (2015-2020)
14.3 South America Opioids Drug Market Size by Type (2015-2020)
14.4 South America Opioids Drug Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Opioids Drug Market Size (2015-2026)
15.2 Rest of the World Opioids Drug Key Players in North America (2015-2020)
15.3 Rest of the World Opioids Drug Market Size by Type (2015-2020)
15.4 Rest of the World Opioids Drug Market Size by Application (2015-2020)
16 Opioids Drug Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Opioids Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|